Gagnon Securities LLC
- SEC CIK
- 0001125725
- Latest filing
- Aug 4, 2026
RNTX holding history
Rein Therapeutics, Inc. in every 13F filed by Gagnon Securities LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RNTX overviewAll 13F holders of RNTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 229,070
- Value
- $238.2K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 229,070 | $238.2K | <0.1% | −10,450−4.4% | Reduced | Holders |
| Q1 2026 | 239,520 | $311.4K | 0.1% | −700−0.3% | Reduced | Holders |
| Q4 2025 | 240,220 | $278.7K | 0.1% | +11,528+5.0% | Added | Holders |
| Q3 2025 | 228,692 | $261.9K | 0.1% | +156,947+218.8% | Added | Holders |
| Q2 2025 | 71,745 | $100.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 71,745 | $127.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 71,745 | $165.0K | <0.1% | −160.0% | Reduced | Holders |
| Q3 2024 | 71,761 | $254.0K | 0.1% | +33,784+89.0% | Added | Holders |
| Q2 2024 | 37,977 | $105.2K | <0.1% | +30+0.1% | Added | Holders |
| Q1 2024 | 37,947 | $251.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 37,947 | $115.7K | <0.1% | +37,947 | New | Holders |